According to our (Global Info Research) latest study, the global Cellular and Gene Therapy CDMO market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This report is a detailed and comprehensive analysis for global Cellular and Gene Therapy CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided. Key Features: Global Cellular and Gene Therapy CDMO market size and forecasts, in consumption value ($ Million), 2017-2028 Global Cellular and Gene Therapy CDMO market size and forecasts by region and country, in consumption value ($ Million), 2017-2028 Global Cellular and Gene Therapy CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2017-2028 Global Cellular and Gene Therapy CDMO market shares of main players, in revenue ($ Million), 2017-2022 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Cellular and Gene Therapy CDMO To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Cellular and Gene Therapy CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Charles River, The Discovery Labs and BIOCENTRIQ, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Cellular and Gene Therapy CDMO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Cell Therapy Viral Vectors Plasmid Market segment by Application Commercial Academic Research Others Market segment by players, this report covers Catalent Lonza Charles River The Discovery Labs BIOCENTRIQ FUJIFILM Diosynth Biotechnologies Exothera WuXi AppTec Pharmaron OBiO Cell Therapies AGC Biologics Cytiva Helixmith ThermoGenesis Anemocyte Thermo Fisher Scientific CBM Bio Elpida Genezen CCRM RoslinCT GenScript ProBio Oxford BioMedica Porton Pharma Solutions Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Cellular and Gene Therapy CDMO product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Cellular and Gene Therapy CDMO, with revenue, gross margin and global market share of Cellular and Gene Therapy CDMO from 2017 to 2022. Chapter 3, the Cellular and Gene Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2017 to 2028. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cellular and Gene Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2023 to 2028. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Cellular and Gene Therapy CDMO. Chapter 13, to describe Cellular and Gene Therapy CDMO research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Cellular and Gene Therapy CDMO 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Cellular and Gene Therapy CDMO by Type 1.3.1 Overview: Global Cellular and Gene Therapy CDMO Market Size by Type: 2017 Versus 2021 Versus 2028 1.3.2 Global Cellular and Gene Therapy CDMO Consumption Value Market Share by Ty